Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.0200 (-2.59%) ($5.9300 - $6.2400) on Thu. Aug. 20, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.43% (three month average) | RSI | 35 | Latest Price | $6.0200(-2.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.5% a day on average for past five trading days. | Weekly Trend | CAPR declines -11% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IGOV(26%) TLT(26%) VCIT(22%) VIXM(18%) CEMB(17%) | Factors Impacting CAPR price | CAPR will decline at least -4.215% in a week (0% probabilities). URA(-38%) XLB(-33%) PAVE(-26%) XOP(-25%) OIH(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.215% (StdDev 8.43%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.27 | 5 Day Moving Average | $6.31(-4.6%) | 10 Day Moving Average | $6.3(-4.44%) | 20 Day Moving Average | $7.27(-17.19%) | To recent high | -38.6% | To recent low | 20.2% | Market Cap | $119m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |